NHS National Generic Pharmaceuticals Wave 13
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 202...
Buyer
ATAMIS LTD
Value
£469,741,550
Published
19 Jan 2022
Closes
26 Jul 2021
Procurement details
Source
Contracts Finder
Region
East Midlands
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Generic Pharmaceuticals Wave 13
£469,741,550
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential pe...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
19 Jan 2022
Opportunity notice on Contracts Finder
Tender notice · Web page
Awarded contract notice on Contracts Finder
19 Jan 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.